TD Cowen 43rd Annual Health Care Conference March 6, 2023 Tom Polen Chairman, CEO, and President Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage targets and capital deployment. All such statements are based upon current expectations of BD and involve a n ...

Becton, Dickinson and Company (NYSE:BDX) Q1 2023 Earnings Conference Call February 2, 2023 8:00 AM ET Company Participants Francesca DeMartino – Senior Vice President and Head-Investor Relations Tom Polen – Chairman, Chief Executive Officer and President Chris DelOrefice – Executive Vice President and Chief Financial Officer Dave Hickey – President-Life Sciences Segment Mike Garrison – President-Medical Segment Conference Call Participants Vijay Kumar – Evercore ISI Matt Taylor – Jefferies Larry Biegelsen – ...

| --- | --- | |------------------------------------------------|-------------------------------------| | | | | | | | Q1 FY23 Earnings Presentation February 2, 2023 | | | | Advancing the world of health TM | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR 1.900% Notes due December 15, 2026 BDX26 New York Stock Exchange 1.401% Notes due May 24, 2023 BDX23A New York Stock Exchange 3.020% Notes due May 24, 2025 BDX25 New York Stock Exchange 0.632% Notes due June 4, 2023 BDX/23A New York Stock Exchange 1.208% Notes due June 4, 2026 BDX/26A New York Stock Exchange 1.213% Notes due February 12, 2036 BDX/36 New York Stock Exc ...

Table of Contents | --- | |--------------------------------------| | | | | | 22-0760120 | | (I.R.S. Employer Identification No.) | | 07417-1880 | | (Zip code) | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to C ...

Becton, Dickinson and Company (NYSE:BDX) Q4 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Francesca DeMartino - SVP & Head, IR Thomas Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Mike Garrison - President of the Medical Segment Dave Hickey - President of Life Sciences Segment Rick Byrd - President of Interventional Segment Conference Call Participants Lawrence Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Robert Marcus - JPMorgan Matthew Tayl ...

Becton Dickinson and Co (NYSE:BDX) Q3 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Francesca DeMartino - SVP & Head, IR Thomas Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Simon Campion - EVP, President, Medical Segment & Interim President, Interventional Segment David Hickey - Executive VP & President, Life Sciences Segment Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Vijay Kumar - Evercore ISI Robert Marcus - JPMorgan Chas ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------|-------------------------------------------- ...

BD to Acquire Parata Systems June 6, 2022 Caution Concerning Forward-Looking Statements This press release contains certain estimates and other forward-looking statements (as defined under Federal securities laws). Forward looking statements generally are accompanied by words such as "will", "expect", or similar words, phrases or expressions. These forwardlooking statements include statements regarding the estimated or anticipated future results of BD and anticipated benefits of the proposed acquisition of ...

| --- | --- | |-------------------------------------------|-------------------------------------| | | | | | | | Q2 FY22 Earnings Presentation May 5, 2022 | | | | | | | Advancing the world of health TM | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage tar ...